Jim Simons Renovo Rx, Inc. Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 27,656 shares of RNXT stock, worth $37,888. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,656
Previous 64,900
57.39%
Holding current value
$37,888
Previous $92,000
70.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RNXT
# of Institutions
29Shares Held
11MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$4.75 Million1.85% of portfolio
-
Awm Investment Company, Inc. New York, NY2.29MShares$3.13 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.84 Million0.0% of portfolio
-
Bank Of The West975KShares$1.34 Million0.27% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL689KShares$943,3500.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $12.4M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...